Evaluation of nanoparticles loaded with benzopsoralen in rat peritoneal exudate cells

International Journal of Pharmaceutics

Volumn 332, Issue 1-2, 2007, Pages 153-160

  Gomes, A J ^a   Faustino, A S ^a   Lunardi, C N ^b   Lunardi, L O ^c   Machado, A E H ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Benzopsoralen; Exudates peritoneal cell; Nanoparticle; PUVA

Indexed keywords

3 ETHOXYCARBONYL 2H BENZOFURO[2,3 F] 1 BENZOPIRAN 2 ONE; BENZOPSORALEN DERIVATIVE; POLYGLACTIN; PSORALEN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; DRUG RELEASE; MALE; MITOCHONDRION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PUVA; RAT; ROUGH ENDOPLASMIC RETICULUM; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET IRRADIATION;

ANIMALS; ASCITIC FLUID; CHEMISTRY, PHARMACEUTICAL; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; ENDOCYTOSIS; KINETICS; LACTIC ACID; MALE; NANOPARTICLES; PARTICLE SIZE; PHOTOSENSITIZING AGENTS; POLYGLYCOLIC ACID; POLYMERS; PSORALENS; PUVA THERAPY; RATS; RATS, WISTAR; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; ULTRAVIOLET RAYS;

EID: 33846893211     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.035     Document Type: Article

References (39)

1. Alleman E., Leroux J., and Gurny R. Polymeric nano and microparticles for the oral delivery of peptides and peptidomimetics. Adv. Drug Deliv. Rev. 34 (1998) 171-183
2. Baras B., Benoit M.A., and Gillard J. Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen. J. Microencapsul. 17 (2000) 485-498
3. Bottiroli G., Croce A.C., Ramponi R., and Vaghi P. Distribution of di-sulfonate aluminum phthalocyanine an Photophrin II in living cells: a comparative fluorometric study. Photochem. Photobiol. 55 (1992) 575-585
4. Canton M., Caffieri S., Dall' Acqua F., and Di Lisa F. PUVA-induced apoptosis involves mitochondrial dysfunction caused by the opening of the permeability transition pore. FEBS Lett. 522 (2002) 168-172
5. Carter D.M., McMacken M.L.V., and Condit E.S. Defense of cutaneous cells against UV irradiation. I. Photomediated binding of trimethyl psoralen to DNA of melanoma cells in culture. J. Invest. Dermatol. 60 (1973) 270-273
6. Chen W., and Lu R. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. J. Microencapsul. 16 (1999) 551-563
7. Cohen S.R., Burkholder D.E., Varga J.M., Carter D.M., and Bartholomew J.C. Cell cycle analysis of cultured mammalian cells after exposure to 4,5′,8-trimethylpsoralen and long-wave ultraviolet light. J. Invest. Dermatol. 76 (1981) 409-413
8. Collins P., Wainwrigth N.J., Amorin N., Lakshmipathi T., and Fergusson J. 8-MOP PUVA for psoriasis: a comparison of minimal phototoxic dose-based regime with a skin-type approach. Br. J. Dermatol. 135 (1996) 248-256
9. Edelson R.L. Treatment of cutaneous T-cell lymphoma. Curr. Prob. Dermatol. 19 (1990) 226
10. Gomes A.J., Lunardi L.O., Marchetti J.M., Lunardi C.N., and Tedesco A.C. Photobiological and ultrastructural studies of nanoparticle of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment. Drug Deliv. 12 (2005) 159-164
11. Gomes A.J., Faustino A.S., Lunardi C.N., Lunardi L.O., Rigoletto T.P., Zaniquelli M.E.D., and Machado A.E.H. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2H-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution. Drug Deliv. 13 (2006) 447-454
12. Hawley A.E., Illum L., and Davis S.S. Lymph node localization of biodegradable nanospheres surface modified with poloxamer and poloxamine block copolymers. FEBS Lett. 400 (1997) 319-323
13. Kompella U.B., Bandi N., and Ayalasomayajula S.P. Poly(lactic acid) nanoparticles for sustained release of budesonide. Drug Deliv. Technol. 1 (2001) 28-34
14. Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J. Nanosci. Nanotechnol. 4 (2004) 484-488
15. Lacasse F.X., Fillion M.C., Phillips N.C., Escher E., McMullen J.N., and Hildgen P. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm. Res. 15 (1998) 312-317
16. Legat F.J., Wolf P., and Kränke B. Anaphylaxis to 5-methoxypsoralen during photochemotherapy. Br. J. Dermatol. 145 (2001) 821-822
17. Lindelöf B., Sigurgeirsson B., Tegner E., Larkö O., Johannesson A., Berne B., Ljunggren B., Andersson T., Mollin L., Nylander-Lundqvist E., and Emtestam L. PUVA and cancer risk: the Swedish follow-up study. Br. J. Dermatol. 141 (1999) 108-112
18. Llano J., Raber J., and Eriksson L.A. Theoretical study of phototoxic reactions of psoralens. J. Photochem. Photobiol. A: Chem. 154 (2003) 235-243
19. Lysenko E.P., Melnikova V.O., Andina E.S., Wunderlich S., Pliquett F., and Potapenko A.Y. Effects of glutathione peroxidase and catalase on hemolysis and methemoglobin modifications induced by photooxidized psoralen. J. Photochem. Photobiol. B: Biol. 56 (2000) 187-195
20. Ma W., Wlaschek M., Hommel C., Schneider L.-A., and Scharffetter-Kochanek K. Psoralen plus UVA (PUVA) induced premature senescence as a model for stress-induced premature senescence. Exp. Gerontol. 37 (2002) 1197-1201
21. Machado A.E.H. Presentation in VIII Congresso Latinoamericano de Fotoquímica y Fotobiologia (ELAFOT). La Plata, Argentina (2004) (Personal Communication)
22. Machado A.E.H., Miranda J.A., Oliveira-Campos A.M.F., Severino D., and Nicodem D.E. Photophysical properties of two new psoralen analogs. J. Photochem. Photobiol. A: Chem. 146 (2001) 75-81
23. Makki S., Muret P., Said A.M., Bassignot P., Humbert P., Agache P., and Millet J. Percutaneous absorption of three psoralens commonly used in therapy: effect of skin occlusion (in vitro study). Int. J. Pharm. 133 (1996) 245-252
24. Man I., Dawe R.S., Ferguson J., and Ibbotson S.-H. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen. Br. J. Dermatol. 151 (2004) 179-182
25. Mariano T.M., Vetrano A.M., Gentile S.L., Heck D.E., Whittemore M.S., Guillon C.D., Jabin I., Rapp R.D., Heindel N.D., and Laskin J.D. Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth. Biochem. Pharmacol. 63 (2002) 31-39
26. Middelkamp-Hup M.A., Pathak M.A., Parrado C., Garcia-Caballero T., Rius-Díaz F., Fitzpatrick T.B., and González S. Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin. J. Am. Acad. Dermatol. 50 (2004) 41-49
27. Okamoto H., Guo Z., and Imamura S. In vitro granuloma formation by spleen cells treated with psoralen plus long-wave ultraviolet radiation. Photochem. Photobiol. 57 (1993) 667-669
28. Oliveira A.M.A.G., Raposo M.M.M., Oliveira-Campos A.M.F., and Machado A.E.H. Synthesis of psoralen analogues based on dibenzofuran. Helv. Chim. Acta 86 (2003) 2900-2907
29. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003) 329-347
30. Panyam J., Sahoo S.K., Prabha S., Bargar T., and Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 262 (2003) 1-11
31. Panyam J., Zhou W.-Z., Prabha S., Sahoo S.K., and Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-coglycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16 (2004) 1217-1226
32. Pires A.L., Honda N.K., and Cardoso C.A.L. A method for fast determination of psoralens in oral solutions of phytomedicines using liquid chromatography. J. Pharm. Biomed. Anal. 36 (2004) 415-420
33. Radakovic-Fijan S., Rappersberger K., Tanew A., Hönigsmann H., and Ortel B. Ultrastructural changes in PAM cells after photodynamic treatment with delta-aminolevulinic acid-induced porphyrins or photosan. J. Invest. Dermatol. (1999) 112
34. Roop S., Guy J., Berl V., Bischoff P., and Lepoittevin J.-P. Synthesis and photocytotoxic activity of new α-methylene-χbutyrolactone-psoralen heterodimers. Bioorg. Med. Chem. 12 (2004) 3619-3625
35. Ruan G., and Feng S.-S. Preparation and characterization of poly(lactic acid)-poly(ethyleneglycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24 (2003) 5037-5044
36. Saiad A., Makki S., Muret P., Humbert P., and Millet J. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study). J. Dermatol. Sci. 14 (1997) 136-144
37. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., Steele Jr. G.D., and Chen L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Cell Biol. 88 (1991) 3671-3675
38. Tatchen J., Kleinschmidt M., and Marian C.M. Electronic excitation spectra and singlet-triplet coupling in psoralen and its sulfur and selenium analogs. J. Photochem. Photobiol. A: Chem. 167 (2004) 201-212
39. Tokura Y. Modulation of cytokine production by 8-methoxypsoralen and UVA. J. Dermatol. Sci. 19 (1999) 114-122